ETF Components for ELLE - Lyxor Global Gender Eqlty (DR) ETF C USD


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
0R01 A -1.19 0.90
0R2F B 0.09 0.88
BVA B 0.00 0.86
0FQI A 0.00 0.86
0KEQ B -0.84 0.86
0M29 A -0.30 0.85
0Q16 A 0.00 0.83
0YO9 A 0.00 0.82
0HOY A 0.52 0.82
0HV2 D 0.00 0.80
0NVV A 0.00 0.79
0HF3 B -3.59 0.79
0KBK B 0.61 0.78
0R1T D -1.81 0.78
0IFA B -0.70 0.77
0I58 F 0.00 0.76
0Q1S D -0.19 0.74
IIG B 0.00 0.73
0KU1 B 0.00 0.72
0IIF D 0.00 0.71
0R3D A -0.87 0.70
0M6S A 0.00 0.70
0K0X A 0.69 0.69
ADM B -0.44 0.69
CCH A 1.15 0.69
0R2Z C 0.00 0.69
0KYY C 0.71 0.68
0IFJ A -0.74 0.68
0HB5 A 0.00 0.68
0QCV D 0.43 0.68
GSK A 0.50 0.68
0KFX C 0.00 0.68
AZN A -0.13 0.67
0QKU D -0.26 0.67
0NOF A 0.74 0.67
0GT1 B 0.00 0.67
WPP A -0.67 0.67
0OJC B 0.00 0.67
LAND A 0.62 0.67
0R1X B 0.04 0.67
NG A 0.52 0.66
0O8F A 0.00 0.66
DSM F -4.62 0.66
ITV B -0.14 0.65
0R3T D 0.00 0.65
XSG F 0.00 0.64
PHNX F 0.58 0.64
0NRE A 0.00 0.64
0CXC B 0.00 0.64
MNG F -0.50 0.64
SSE B 1.46 0.63
0IIW C 1.25 0.62
0HJF F -1.69 0.62
ULVR A 0.36 0.62
0R0G C -2.13 0.61
0HJI A 3.57 0.61
0G8C A 0.00 0.61
0Y0Y F -0.19 0.60
0HEW B 1.54 0.59
0A6B A 5.81 0.59
0OQV F 0.00 0.59
0I8Y C 0.00 0.59
VOD D 0.67 0.58
0QLR A 0.00 0.58
TATE B -1.14 0.57
0J3F D 0.00 0.57
0J4X C -0.82 0.56
STAN A 6.13 0.56
SDR F -0.11 0.54
0M3Q D -0.85 0.53
0J8Z F -0.37 0.52
0LSZ F -2.78 0.48
0O7D F 0.00 0.48
0R1B C 0.36 0.47
0A4S F -0.19 0.46
0IIH F 0.00 0.46
0O46 F 0.00 0.43
0NZM A 0.00 0.37

Recent News for Lyxor Global Gender Eqlty (DR) ETF C USD & its Holdings

Date Stock Title
May 2 GSK GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 1 ULVR Showdown at Unilever AGM as activists challenge board over environmental impact
May 1 AZN AstraZeneca admits Covid-19 vaccine may cause blood clots in “very rare” cases
May 1 GSK GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
May 1 GSK GSK raises profit guidance as vaccine demand grows
May 1 GSK GSK (GSK) Q1 Earnings and Revenues Surpass Estimates
May 1 AZN AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio
May 1 GSK Trending tickers: Amazon, AMD, GSK and Aston Martin
May 1 GSK GSK Lifts Guidance After Turnover Beats Expectations
Apr 30 VOD Abu Dhabi’s E& Eyes €8 Billion Telecom Firm United Group
Apr 30 GSK Update: FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications
Apr 30 AZN AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript
Apr 29 AZN AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism Unknown
Apr 29 AZN AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
Apr 29 AZN AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement
Apr 29 NG Economic Growth Slows Triggering Slowdown Fears: 5 Safe Bets
Apr 29 AZN AstraZeneca, Daiichi look to broaden Enhertu use again with new study data
Apr 29 AZN ENHERTU® (fam-trastuzumab deruxtecan-nxki) improved PFS in HER2-low and ultralow
Apr 27 AZN AstraZeneca PLC (LON:AZN) Beat Earnings, And Analysts Have Been Reviewing Their Forecasts
Apr 26 AZN Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
The investment objective of Lyxor Index Fund - Lyxor Global Gender Equality (DR) UCITS ETF is to track both the upward and the download evolution of the "Solactive Equileap Global Gender Equality Nety Total Return Index" denominated in USD in order to offer an exposure to the performance of global leading companies in the field of gender equality.
Exchange Traded Funds ETF Index Fund Quality Total Return Index European Union Law Topix Solactive Equileap Gender Equality
Back to the Main ELLE Page...